What Researchers Did
The researchers checked the heart tracings of diabetic patients before and after a course of hyperbaric oxygen (HBO) therapy that was planned for non-healing leg ulcers.
What They Found
In a clinical study of 30 diabetic patients, the QTc dispersion, a heart-rhythm measure taken from an electrocardiogram, fell from 59.8 msec to 52.2 msec after ten HBO sessions (p less than 0.05). The patients were 18 men and 12 women, with an average age of 59.9 years. Each had an electrocardiogram before the first session and after the 10th session, given over two weeks. The maximum, minimum and mean QTc did not change significantly.
What This Means for Canadian Patients
For people with diabetes who are planning HBO therapy for non-healing leg ulcers, this study looked at one heart-rhythm measure before and after ten sessions. It found a small drop in QTc dispersion and no significant change in the other QTc measures. The abstract did not measure actual arrhythmias or sudden cardiac death, so the study cannot show that HBO therapy changes those outcomes.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study had only 30 patients, no comparison group and a before-and-after design, so it cannot show that HBO therapy caused the change. It also measured an ECG index rather than arrhythmias or sudden cardiac death. The authors' conclusion that HBO therapy "may" reduce that risk is a suggestion, not something the study tested.